Clinical Trials
5 trialsNCT06448169 2024-06-07
Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer
Shandong University
Unknown
NCT04914390 2024-01-22
NeoATCT
Sichuan Provincial People's Hospital
Phase 2 Unknown
NCT04734262 2023-11-18
SPARK
Fudan University
Phase 2 Unknown
NCT05746728 2023-04-06
Surufatinib Combined With Tislelizumab in the Second-line and Further Treatment of Triple-negative Breast Cancer
Tongji Hospital
Phase 1/2 Unknown
NCT04913571 2021-06-04
TEMPLATE
Fudan University
Phase 2 Unknown